LoginSign Up
Scaled Biolabs

Scaled Biolabs

Scaled Biolabs has developed a platform based on microfluidic technology that allows researchers to perform thousands of simultaneous cell culture experiments.

Scaled Biolabs has developed a new platform based on microfluidic technology spun-out of The University of Queensland's Australian Institute for Bioengineering and Nanotechnology that allows researchers to perform thousands of simultaneous cell culture experiments.

Scaled Biolabs is developing a Cell Therapy Discovery Engine to create cell-based medicines. This engine allows biotech and pharma companies to survey hundreds of parameters across tens of thousands of experimental processes. Scaled Biolabs also develops cell therapy assets internally, including a CIRM-funded program focusing on iPSC-derived dopaminergic neurons as a curative cell therapy for Parkinson's disease.

Timeline

People

Name
Role
Related Golden topics

Brendan Griffen

Founder

Drew Titmarsh

Founder, CEO

Justin Cooper-White

Founder

Further reading

Title
Author
Link
Type

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References